WEI LUO: Open Payments
NPI 1528659836 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 16 payments from 13 companies in 2025. Trend: 2023 $649 · 2024 $581 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $244 |
| Gilead Sciences, Inc. | 2 | $234 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $116 |
| Medtronic, Inc. | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| Corcept Therapeutics | 1 | $93 |
Products named: EVENITY, BENLYSTA, UZEDY, Epclusa, TEPEZZA, CERDELGA, Yeztugo, INTERSTIM.
Industry payments across MI — which companies pay providers there.
